Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shashank Kulkarni

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Frontiers in Pharmacology|October 26, 2020
Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl MetaboliteChandrashekhar Honrao, Xiaoyu Ma, Shashank Kulkarni, et al.
Frontiers in Pharmacology|May 10, 2021
Corrigendum: Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl MetaboliteChandrashekhar Honrao, Xiaoyu Ma, Shashank Kulkarni, et al.
ACS Infectious Diseases|September 13, 2022
Modulation of Host-Parasite Interactions with Small Molecules Targeting <i>Schistosoma mansoni</i> microRNAsYoussef Hamway, Kaspar Zimmermann, Marcel J J Blommers, et al.
Journal of Medicinal Chemistry|July 2, 2016
Novel C-Ring-Hydroxy-Substituted Controlled Deactivation Cannabinergic AnaloguesShashank Kulkarni, Spyros P Nikas, Rishi Sharma, et al.
Journal of Medicinal Chemistry|November 30, 2013
Controlled-deactivation cannabinergic ligandsRishi Sharma, Spyros P Nikas, Carol A Paronis, et al.
Journal of Medicinal Chemistry|December 4, 2014
Probing the carboxyester side chain in controlled deactivation (-)-δ(8)-tetrahydrocannabinolsSpyros P Nikas, Rishi Sharma, Carol A Paronis, et al.
Bioorganic & Medicinal Chemistry|May 1, 2021
Discovery of potent and selective reversible Bruton's tyrosine kinase inhibitorsHui Qiu, Zahid Ali, Andrew Bender, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Frontiers in Pharmacology|October 26, 2020
Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl MetaboliteChandrashekhar Honrao, Xiaoyu Ma, Shashank Kulkarni, et al.
Frontiers in Pharmacology|May 10, 2021
Corrigendum: Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl MetaboliteChandrashekhar Honrao, Xiaoyu Ma, Shashank Kulkarni, et al.
ACS Infectious Diseases|September 13, 2022
Modulation of Host-Parasite Interactions with Small Molecules Targeting <i>Schistosoma mansoni</i> microRNAsYoussef Hamway, Kaspar Zimmermann, Marcel J J Blommers, et al.
Journal of Medicinal Chemistry|July 2, 2016
Novel C-Ring-Hydroxy-Substituted Controlled Deactivation Cannabinergic AnaloguesShashank Kulkarni, Spyros P Nikas, Rishi Sharma, et al.
Journal of Medicinal Chemistry|November 30, 2013
Controlled-deactivation cannabinergic ligandsRishi Sharma, Spyros P Nikas, Carol A Paronis, et al.
Journal of Medicinal Chemistry|December 4, 2014
Probing the carboxyester side chain in controlled deactivation (-)-δ(8)-tetrahydrocannabinolsSpyros P Nikas, Rishi Sharma, Carol A Paronis, et al.
Bioorganic & Medicinal Chemistry|May 1, 2021
Discovery of potent and selective reversible Bruton's tyrosine kinase inhibitorsHui Qiu, Zahid Ali, Andrew Bender, et al.
Pageof 2